Listing

Artelo Biosciences Regains Compliance with Nasdaq Itemizing Necessities
Stock Market

Artelo Biosciences Regains Compliance with Nasdaq Itemizing Necessities

Visionary Holdings Inc. Declares Receipt of Nasdaq Continued Itemizing Deficiency Letter
Stock Market

Visionary Holdings Inc. Declares Receipt of Nasdaq Continued Itemizing Deficiency Letter

Crypto Information: Pepeto CoinMarketCap Itemizing Replace Whereas BNB Worth Prediction Targets ,100 Forward of Bull Run
Press Releases

Crypto Information: Pepeto CoinMarketCap Itemizing Replace Whereas BNB Worth Prediction Targets $1,100 Forward of Bull Run

Pepeto Pronounces Binance Itemizing Progress Whereas Markets Wait For XRP Value To Attain The Mark – Crypto Information
Press Releases

Pepeto Pronounces Binance Itemizing Progress Whereas Markets Wait For XRP Value To Attain The $10 Mark – Crypto Information

New Crypto Pepeto Binance Itemizing Replace Following Shiba Inu Success and Cardano Worth Prediction Goal
Company Announcement

New Crypto Pepeto Binance Itemizing Replace Following Shiba Inu Success and Cardano Worth Prediction Goal

Crypto Information: Ethereum Primarily based Crypto Pepeto Nears Binance Itemizing as Cardano Worth Prediction Targets a Robust Restoration
Press Releases

Crypto Information: Ethereum Primarily based Crypto Pepeto Nears Binance Itemizing as Cardano Worth Prediction Targets a Robust Restoration

Crypto Information: Pepeto Reveals Binance Itemizing Approaching as Market Asks If XRP Value Prediction Can Attain
Company Announcement

Crypto Information: Pepeto Reveals Binance Itemizing Approaching as Market Asks If XRP Value Prediction Can Attain $50

Crypto Information: Ethereum Based mostly Crypto Pepeto Approaches Binance Itemizing Whereas Cardano Worth Prediction Eyes Sturdy Restoration
Press Releases

Crypto Information: Ethereum Based mostly Crypto Pepeto Approaches Binance Itemizing Whereas Cardano Worth Prediction Eyes Sturdy Restoration

BridgeBio Pharma Reviews Inducement Grants below Nasdaq Itemizing Rule 5635(c)(4)
Product / Services

BridgeBio Pharma Reviews Inducement Grants below Nasdaq Itemizing Rule 5635(c)(4)

EyePoint Studies Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4)
Stock Market

EyePoint Studies Inducement Grants Beneath NASDAQ Itemizing Rule 5635(c)(4)